SecSonar.com

Pliant Therapeutics, Inc. (PLRX)

Pliant Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Pliant Therapeutics, Inc. (PLRX) is a Biotechnology company based in US with a market capitalization of $78M. Free cash flow was negative at -$128.7M. This page tracks PLRX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 171 employees · IPO Jun 3, 2020

Valuation

Valuation & price

$1.15 · as of May 17, 2026 · -38.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.43

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.87$1.49$1.11Jul 25Dec 25Jul 26Jul 7, 25$1.18Jul 9, 25$1.36Jul 11, 25$1.41Jul 15, 25$1.39Jul 17, 25$1.42Jul 21, 25$1.45Jul 23, 25$1.58Jul 25, 25$1.57Jul 29, 25$1.46Jul 31, 25$1.46Aug 4, 25$1.70Aug 6, 25$1.69Aug 11, 25$1.70Aug 13, 25$1.60Aug 15, 25$1.55Aug 19, 25$1.47Aug 21, 25$1.45Aug 25, 25$1.49Aug 27, 25$1.69Aug 29, 25$1.64Sep 3, 25$1.71Sep 5, 25$1.86Sep 9, 25$1.75Sep 11, 25$1.65Sep 16, 25$1.53Sep 18, 25$1.49Sep 22, 25$1.50Sep 24, 25$1.46Sep 26, 25$1.52Sep 30, 25$1.48Oct 2, 25$1.50Oct 6, 25$1.49Oct 8, 25$1.53Oct 10, 25$1.47Oct 14, 25$1.51Oct 16, 25$1.65Oct 21, 25$1.87Oct 23, 25$1.75Oct 27, 25$1.80Oct 29, 25$1.74Oct 31, 25$1.68Nov 4, 25$1.61Nov 6, 25$1.53Nov 10, 25$1.62Nov 12, 25$1.80Nov 14, 25$1.68Nov 18, 25$1.57Nov 20, 25$1.56Nov 25, 25$1.57Nov 28, 25$1.61Dec 2, 25$1.49Dec 4, 25$1.31Dec 8, 25$1.28Dec 10, 25$1.28Dec 12, 25$1.23Dec 16, 25$1.25Dec 18, 25$1.21Dec 22, 25$1.24Dec 24, 25$1.23Dec 29, 25$1.23Jan 2, 26$1.25Jan 6, 26$1.28Jan 8, 26$1.31Jan 12, 26$1.33Jan 14, 26$1.31Jan 16, 26$1.29Jan 21, 26$1.26Jan 23, 26$1.30Jan 27, 26$1.27Jan 29, 26$1.24Feb 2, 26$1.19Feb 4, 26$1.18Feb 9, 26$1.17Feb 11, 26$1.15Feb 13, 26$1.11Feb 18, 26$1.25Feb 20, 26$1.24Feb 24, 26$1.27Feb 26, 26$1.29Mar 2, 26$1.27Mar 4, 26$1.29Mar 6, 26$1.33Mar 10, 26$1.39Mar 12, 26$1.41Mar 17, 26$1.33Mar 19, 26$1.33Mar 23, 26$1.29Mar 25, 26$1.31Mar 27, 26$1.17Mar 31, 26$1.26Apr 2, 26$1.35Apr 7, 26$1.31Apr 9, 26$1.35Apr 13, 26$1.30Apr 15, 26$1.31Apr 17, 26$1.33Apr 22, 26$1.29Apr 24, 26$1.24Apr 28, 26$1.21Apr 30, 26$1.22May 4, 26$1.19May 6, 26$1.23May 8, 26$1.22May 12, 26$1.18May 14, 26$1.17May 18, 26$1.18May 20, 26$1.20May 22, 26$1.21May 28, 26$1.25Jun 1, 26$1.20Jun 3, 26$1.18Jun 5, 26$1.15Jun 9, 26$1.19Jun 11, 26$1.14Jun 15, 26$1.14Jun 17, 26$1.18Jun 22, 26$1.16Jun 24, 26$1.13Jun 26, 26$1.14Jul 2, 26$1.17
$1.0952-week range$1.87
Loading valuation history…

Fundamentals

Key fundamentals

$78M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$128.7M

Free cash flow (USD)

-$161.8M

Net debt

Net cash position

1.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$0.00FY 2018$0.00FY 2019$57.1MFY 2020$41.8MFY 2021$7.6MFY 2022$9.7MFY 2023$1.6MFY 2024$0.00FY 2025$0.00
$0$0

Free cash flow by year

2017 → 2025

FY 2017$-18.3MFY 2018$-30.7MFY 2019$-3.7MFY 2020$-38.8MFY 2021$-77.4MFY 2022$-96.4MFY 2023$-117.3MFY 2024$-159.4MFY 2025$-128.7M
-$18.3M-$128.7M

Gross margin by year

2021 → 2023

FY 2021100.0%FY 2022100.0%FY 2023100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 11, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 11, 2026Filing
  • 8-K eventCorporate Update and Financial ResultsMay 11, 2026Filing
  • Quarterly report10-Q FiledMay 11, 2026Filing
  • 8-K eventBoard Member RetirementsApr 17, 2026Filing

Questions

Frequently asked questions

What is Pliant Therapeutics, Inc.'s market cap?

Pliant Therapeutics, Inc. (PLRX) has a market capitalization of $78M.

What is PLRX's P/E ratio?

A meaningful P/E ratio is not available for PLRX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PLRX's price-to-book (P/B) ratio?

PLRX trades at 0.43 times book value per share.

Are insiders buying PLRX stock?

SEC Form 4 filings show no open-market insider buys at Pliant Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

NRXP

NRx Pharmaceuticals, Inc.

$78.1M

KPTI

Karyopharm Therapeutics Inc.

$77.4M

RLYB

Rallybio Corporation

$76.3M

CSBR

Champions Oncology, Inc.

$81M

HYFT

MindWalk Holdings Corp.

$82M

GANX

Gain Therapeutics, Inc.

$82.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.